Clinical Trial Update: Micafungin Salvage Mono-therapy in Invasive Aspergillosis [Phase 2]

View source ↗

Summary

A Phase 2 trial of micafungin as salvage monotherapy for invasive aspergillosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Invasive Aspergillosis | Phase 2 | Status: TERMINATED